Treatment of Weil's Syndrome (Severe Leptospirosis)
Despite limited evidence of benefit in severe disease, antibiotics (penicillin or tetracyclines) should be initiated immediately upon clinical suspicion, combined with aggressive supportive care including renal replacement therapy and intensive monitoring for multi-organ failure. 1
Antibiotic Therapy
Start antibiotics empirically without waiting for diagnostic confirmation, given the non-specific nature of initial investigations and potential for rapid deterioration 1.
Recommended Regimens:
- Penicillin (intravenous) - traditional first-line for severe disease 1, 2
- Ceftriaxone 2g IV daily - increasingly used alternative 3
- Doxycycline - effective if given within first several days 4
Critical Evidence Caveat:
The guidelines acknowledge an important limitation: a systematic review showed no benefit for antibiotic treatment in established leptospirosis based on three trials 1. However, most infectious disease specialists continue recommending antibiotics because:
- Severe disease is likely immunologically mediated (occurring during the immune phase)
- Antibiotics are effective during the bacteremic phase
- The risk-benefit ratio favors treatment despite limited evidence
Supportive Care - The True Cornerstone
Aggressive supportive management is essential and may be more critical than antibiotics in determining outcomes 1.
Renal Support:
- Daily hemodialysis for acute kidney injury 5
- Sustained low-efficiency dialysis (SLED) for hemodynamically unstable patients 6
- Monitor for characteristic nonoliguric renal failure with hypokalemia 5
Fluid Management:
- Maintain low daily net fluid intake (I=O+500ml) due to high risk of pulmonary hemorrhage 3, 5
- Adequate fluid resuscitation balanced against pulmonary complications 3
Hepatic Support:
- Monitor for progressive hyperbilirubinemia
- Liver support as needed for hepatorenal syndrome 1
Respiratory Management:
- Lung-protective ventilation strategies if ARDS develops: low tidal volumes and high PEEP after recruitment maneuvers 5
- Monitor closely for diffuse alveolar hemorrhage and pulmonary edema 5
Controversial: Corticosteroid Therapy
Recent case reports suggest potential benefit from corticosteroids in severe, refractory cases:
- Methylprednisolone 1 mg/kg/day showed dramatic improvement within 24 hours in one 2026 case 7
- Intravenous corticosteroids with supportive care alone (without antibiotics) resulted in recovery in another case 8
- Therapeutic plasma exchange (TPE) may serve as rescue therapy in complex cases with aHUS-like features 6
However, this remains experimental and not guideline-recommended. Consider only in patients with progressive deterioration despite appropriate antibiotic and supportive therapy, recognizing that severe disease is immunologically mediated 1.
Clinical Pitfalls to Avoid
- Do not wait for serological confirmation - IgM positivity appears 6-10 days after symptom onset; treat on clinical suspicion 1
- Avoid nephrotoxic drugs in patients with renal involvement 3
- Do not aggressively fluid resuscitate - balance against pulmonary hemorrhage risk 5
- Blood cultures must be kept at room temperature before dispatch to reference laboratory 1
- Recognize that patients can deteriorate despite therapy - jaundice signals severe disease requiring ICU-level monitoring 1
Prognosis
Most patients, even with severe disease, recover without residual organ impairment if they survive the acute phase 4. However, Weil's disease carries significant mortality risk, particularly with pulmonary hemorrhage, and some patients remain dialysis-dependent at discharge 6, 9.